Using Equivalent Income Concept in Blood Pressure Lowering Drugs Assessment. How Include Inequality Aversion in Cost/Benefit Analysis?

Anne-Laure Samson, Clémence Thebaut (), Brigitte Dormont, Marc Fleurbaey, Stéphane Luchini (), Erik Schokkaert and Carine van de Voorde
Additional contact information
Clémence Thebaut: LEDa - Laboratoire d'Economie de Dauphine - Université Paris Dauphine-PSL - PSL - Université Paris Sciences et Lettres
Stéphane Luchini: GREQAM - Groupement de Recherche en Économie Quantitative d'Aix-Marseille - EHESS - École des hautes études en sciences sociales - AMU - Aix Marseille Université - ECM - École Centrale de Marseille - CNRS - Centre National de la Recherche Scientifique
Carine van de Voorde: KU Leuven - Catholic University of Leuven = Katholieke Universiteit Leuven

Post-Print from HAL

Abstract: Health equivalent income concept [...]

Keywords: Cost/Benefit; Analysis (search for similar items in EconPapers)
Date: 2014-06-16
References: Add references at CitEc
Citations:

Published in Health Technology Assessment international annual meeting (HTAi 2014), Jun 2014, Washington, DC, United States

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-01475275

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().